KONINKLIJKE PHILIPS N.V., Medtronic and GE Healthcare Dominated the Market for Global Vital Signs Monitoring Market in 2016

Global Vital Signs Monitoring Market is expected to reach USD 6,696.59 million by 2024 from USD 4,125.00 million in 2016, at a CAGR of 6.5% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Based on product type, portable mobile power bank market has the largest market segment in power bank market.

Access Full Reporthttp://databridgemarketresearch.com/reports/global-vital-signs-monitoring-devices-market/Global Vital Signs Monitoring MarketThe global vital signs monitoring market is highly concentrated market with major key players and local players to cater the domestic market. KONINKLIJKE PHILIPS N.V. is dominating the vital signs monitoring market followed by Medtronic and GE Healthcare along with others such as Welch Allyn, Inc., A&D Medical, Contec Medical Systems, Masimo Corporation, Mindray Medical International Limited, Nihon Kohden, Omron Healthcare, Inc., Smiths Medical, Dragerwerk AG & Co. KGaA, CAS Medical Systems, Inc., Spacelabs Healthcare, Inc., Boston Scientific, Nonin Medical, Natus Medical, Hicks Thermometers (India) Limited, and Halma plc among others holds 18.1% of the global vital signs monitoring market in 2016.

KONINKLIJKE PHILIPS N.V.:

Founded in 1891 and headquartered in Amsterdam, Netherlands. Koninklijke Philips N.V. provides the innovative solution at lower cost. The company operates in personal health, diagnosis & treatment, connected care & health informatics, lighting and legacy items business segments. The company operates in more than 122 countries worldwide with more than 82 production sites. The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe.

Medtronic:

Founded in 1949 and headquartered Minneapolis, U.S. Medtronic is the world’s largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, Diabetes service and solutions.

GE Healthcare:

Founded in 2004 and headquartered Little Chalfont, United Kingdom. GE healthcare provides transformational medical technologies and services. GE health care operates through three business segments health care systems, life sciences and healthcare digital.  The healthcare systems segment offers a wide range of products for diagnostic imaging and clinical systems. Diagnostic imaging systems such as digital mammography, X-ray, computed tomography (CT), surgical and interventional imaging, magnetic resonance (MR) and molecular imaging technologies. Clinical systems comprises of ultrasound, bone densitometry, electrocardiography (ECG), patient monitoring, incubators, infant warmers, respiratory care, and anesthesia management. Life Sciences segment delivers products, services and manufacturing solutions for drug discovery, the biopharmaceutical industry and cellular technologies. Healthcare digital segment provides medical technologies, software, analytics, cloud solutions.